Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biofil Chemicals & Pharmaceuticals has informed the exchanges that its trading window will be closed from April 1, 2026, in line with SEBI's Insider Trading Regulations. The closure applies to designated persons, their immediate relatives, and connected persons. The window is being shut ahead of the company's audited financial results for the quarter and full financial year ending March 31, 2026. The trading window will reopen 48 hours after the audited results are officially announced to the stock exchanges. The board meeting date to approve these results will be communicated later. This is a routine compliance filing and does not indicate any corporate action.
No direct impact on shareholders or stock price. This is a standard regulatory compliance announcement ahead of the company's annual financial results, meant to prevent insider trading by company insiders during a sensitive period.